deltatrials
Recruiting NCT04397978

Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases

Sponsor: Universitaire Ziekenhuizen KU Leuven

Updated 9 times since 2020 Last updated: Jun 28, 2024 Started: Oct 10, 2020 Primary completion: Jun 1, 2025 Completion: Jun 1, 2025

Listed as NCT04397978, this observational or N/A phase trial focuses on Brain Metastases, Adult and remains actively recruiting participants. Sponsored by Universitaire Ziekenhuizen KU Leuven, it has been updated 9 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Recruiting

  2. Aug 2024 — Sep 2024 [monthly]

    Recruiting

  3. Jul 2024 — Aug 2024 [monthly]

    Recruiting

  4. Jun 2023 — Jul 2024 [monthly]

    Recruiting

  5. Nov 2022 — Jun 2023 [monthly]

    Recruiting

Show 4 earlier versions
  1. Nov 2021 — Nov 2022 [monthly]

    Recruiting

  2. Jan 2021 — Nov 2021 [monthly]

    Recruiting

  3. Dec 2020 — Jan 2021 [monthly]

    Recruiting

  4. Jun 2020 — Dec 2020 [monthly]

    Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Universitaire Ziekenhuizen KU Leuven
Data source: Universitaire Ziekenhuizen KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • Leuven, Belgium